Daratumumab for multidrug-resistant phospholipase-A2 receptor–related membranous nephropathy
Coralien H. Vink, Bram van Cranenbroek, Joost W van der Heijden, Hans P.J.M. Koenen, Jack F.M. Wetzels
Topics & Concepts
RituximabBortezomibMedicineMembranous nephropathyInternal medicinePlasma cellDaratumumabImmunologyAntibodyOncologyMultiple myelomaGlomerulonephritisKidneyAmyloidosis: Diagnosis, Treatment, OutcomesRenal Diseases and GlomerulopathiesCoagulation, Bradykinin, Polyphosphates, and Angioedema